Humanized mouse model: A model to understand mechanisms of immune non-responsiveness to immune checkpoint inhibitors in melanoma.

被引：0

作者：

Somasundaram, Rajasekharan ^{[1
]}

Samarkina, Anastasia ^{[1
]}

Connelly, Thomas ^{[1
]}

Choi, Robin ^{[1
]}

Choi, Hedy ^{[1
]}

Muthumani, Kar ^{[1
]}

Xu, Xiaowei ^{[2
]}

Kaestner, Klaus ^{[2
]}

Herlyn, Meenhard ^{[1
]}

机构：

[1] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA

[2] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA

来源：

CANCER RESEARCH | 2020年 / 80卷 / 19期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A26

引用

页码：43 / 43

页数：1

共 50 条

[1] Modeling intracranial responses to immune checkpoint inhibitors in a mouse melanoma model
Taggart, David
Andreou, Tereza
Scott, Karen
Williams, Jennifer
Rippaus, Nora
Brownlie, Rebecca
Ilett, Elizabeth
Salmond, Robert
Melcher, Alan
Lorger, Mihaela
[J]. CLINICAL & EXPERIMENTAL METASTASIS, 2017, 34 (08) : 510 - 510
[2] A prediction model for response to immune checkpoint inhibition in advanced melanoma.
van Duin, Isabella A. J.
Verheijden, Rik Jasper
van Diest, Paul J.
van den Eertwegh, Alfonsus Johannes Maria
de Groot, Jan Willem
van Not, Olivier Jules
Aarts, Maureen J. B.
Van den Berkmortel, Franchette
Blank, Christian U.
Haanen, John B. A. G.
Hospers, Geke
Piersma, Djura
van Rijn, Rozemarijn
Van der Veldt, Astrid Aplonia Maria
Vreugdenhil, Gerard
Stevense-den Boer, Marion
Boers-Sonderen, Marye J.
Kapiteijn, Ellen
Suijkerbuijk, Karijn
Elias, Sjoerd G.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[3] Efficacy of immune checkpoint inhibitors (ICIs) for in-transit melanoma.
Tie, Emilia Nan
Lai-Kwon, Julia Elizabeth
Na, Lumine
Rtshiladze, Michael Alexander
Bozzi, James
Read, Tavis
Atkinson, Victoria
Au-Yeung, George
Long, Georgina V.
McArthur, Grant A.
Sandhu, Shahneen Kaur
Saw, Robyn
Walpole, Euan Thomas
Menzies, Alexander M.
Smithers, B. Mark
Gyorki, David E.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[4] Treatment beyond progression with immune checkpoint inhibitors in advanced melanoma.
Sobczuk, Pawel
Czarnecka, Anna Malgorzata
Spalek, Mateusz
Teterycz, Pawel
Dudzisz-Sledz, Monika
Switaj, Tomasz
Rogala, Pawel
Placzke, Joanna
Kozak, Katarzyna
Borkowska, Aneta
Kosela-Paterczyk, Hanna
Rutkowski, Piotr
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[5] A humanized mouse model for translational assessment of targeted immune checkpoint blockade
Baia, Gilson
Vasquez-Dunddel, David
Ciznadija, Daniel
Sidransky, David
Katz, Amanda
Paz, Keren
[J]. CANCER RESEARCH, 2015, 75
[6] Mechanisms of primary resistance to immune checkpoint inhibitors in Melanoma
Moogk, Duane
Wang, Lin
Li, Kaitao
Yuan, Zhou
Zhong, Shi
Yu, Zhiya
Liadi, Ivan
Rittase, William
Fang, Victoria
Dougherty, Janna
Perez-Garcia, Arianne
Varadarajan, Navin
Restifo, Nicholas P.
Frey, Alan
Osman, Iman
Weber, Jeff
Zhu, Cheng
Krogsgaard, Michelle
[J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17
[7] Caloric restriction mimetics as adjuvant to immune checkpoint inhibitors for treatment of melanoma.
Morehead, Lauren C.
Koss, Brian S.
Wallis, Katherine F.
Tackett, Alan J.
Miousse, Isabelle Racine
[J]. CANCER RESEARCH, 2021, 81 (13)
[8] Evaluation of the clinical benefits of immune checkpoint inhibitors in patients with advanced melanoma.
Ou, Qiyun
Yu, Yunfang
Lin, Dagui
Fu, Tuping
Gao, Quanlong
Luo, Baoming
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
[9] Enhancing the efficacy of antitumor antibodies with immune checkpoint inhibitors and targeted therapy in melanoma.
Perez-Lorenzo, Rolando
Erjavec, Stephanie O.
Clynes, Raphael
Christiano, Angela M.
[J]. CANCER RESEARCH, 2021, 81 (13)
[10] Evaluating the Effect of Immune Checkpoint Inhibitors in Colorectal Cancer Using a Humanized Murine Model
Lam, Cyrena
Ray, Alicia Nicole
Maresh, Grace
Zhang, Xin
Baer, Hallie
Haupt, Carl
Simon, Jessica
Paruch, Jennifer
Li, Li
[J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S179 - S180

← 1 2 3 4 5 →